Selected article for: "acute respiratory syndrome and China coronavirus outbreak"
Author: Russell, Beth; Moss, Charlotte; Rigg, Anne; Van Hemelrijck, Mieke
Title: COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
  • Document date: 2020_3_30
    • ID: 0uengr9t_3
    Snippet: Across Europe, the incidence and mortality rates of COVID-19 or severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) continue to rise dramatically. The disease is named due to the similarities to the SARS outbreak in China of 2002, which was also caused by a coronavirus. However, SARS-CoV-2 is thought to be caused by a novel coronavirus not seen before. Alongside uncertainty related to infection aetiology and outcomes, emerging concerns .....
    Document: Across Europe, the incidence and mortality rates of COVID-19 or severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) continue to rise dramatically. The disease is named due to the similarities to the SARS outbreak in China of 2002, which was also caused by a coronavirus. However, SARS-CoV-2 is thought to be caused by a novel coronavirus not seen before. Alongside uncertainty related to infection aetiology and outcomes, emerging concerns relate to the use of common non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids. The Belgian Federal Agency for Medicines and Health Products released a statement on 16th March 2020 stating 'It is well known that NSAIDs and corticosteroids can lead to serious complications'. Equally, a report by French Authorities suggested the use of ibuprofen in COVID-19 patients was detrimental to patient condition and recovery. NSAIDs are often used for the management of mild pain in cancer patients; hence, this topic is of particular importance to these patients. We, therefore, sought to gather information on the use of NSAIDs or corticosteroids and COVID-19, through systematic review of existing literature.

    Search related documents:
    Co phrase search for related documents
    • anti inflammatory drug and information gather: 1
    • anti inflammatory drug and mild pain: 1
    • anti inflammatory drug and non steroidal NSAIDs anti inflammatory drug: 1, 2
    • anti inflammatory drug and novel coronavirus: 1, 2, 3, 4, 5
    • anti inflammatory drug and NSAIDs anti inflammatory drug: 1, 2
    • anti inflammatory drug and patient condition: 1
    • anti inflammatory drug and respiratory syndrome corona virus: 1
    • anti inflammatory drug and SARS outbreak: 1, 2, 3
    • cancer patient and mortality incidence: 1, 2, 3, 4, 5, 6, 7
    • cancer patient and mortality incidence rate: 1
    • cancer patient and novel coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • cancer patient and particular importance: 1, 2
    • cancer patient and patient condition: 1, 2, 3
    • cancer patient and SARS outbreak: 1, 2, 3, 4, 5, 6
    • complication lead and coronavirus cause: 1
    • complication lead and novel coronavirus: 1, 2
    • coronavirus cause and information gather: 1
    • coronavirus cause and mortality incidence: 1, 2
    • coronavirus cause and mortality incidence rate: 1